From his time in the industry before the contemporary good manufacturing practice (cGMP), senior drug substance consultant at DSI, a ProductLife Group company, Dave Adams quickly grasped the necessity ...
ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...
10d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
This upcoming webinar from Pharmaron Beijing Co., Ltd. examines the current market demand and trends for the late-phase manufacture and supply of small molecule drug substances. A range of speakers ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results